Page last updated: 2024-08-21

pyrazines and lovastatin

pyrazines has been researched along with lovastatin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (60.00)18.2507
2000's3 (30.00)29.6817
2010's0 (0.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Blankley, CJ; Krause, BR; Newton, RS; Picard, JA; Roark, WH; Roth, BD; Sekerke, C; Shaw, MK; Sliskovic, DR; Stanfield, RL1
Alberti, KG; Dyer, RG; Laker, MF; Stewart, MW1
Cummings, MH; Watts, GF1
Cramb, R; Head, A; Jakeman, PM; Kendall, MJ; Maxwell, S1
Birkenhäger, JC; De Heide, L; Deckers, JW; Hoogerbrugge, N; Jansen, H; Zillikens, MC1
Chan, DC; Chow, CC; Cockram, CS; Ko, GT; Lam, CW; Mak, TW; Tsang, LW; Yeung, VT1
Chng, WJ; Lau, LG; Mow, BM; Yusof, N1
Brossart, P; Fröhlich, E; Wahl, R1
DiGregorio, RV; Pasikhova, Y1
Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB1

Reviews

1 review(s) available for pyrazines and lovastatin

ArticleYear
Targeted therapy in multiple myeloma.
    Cancer control : journal of the Moffitt Cancer Center, 2005, Volume: 12, Issue:2

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Clinical Trials as Topic; DNA, Antisense; Drug Delivery Systems; Farnesyltranstransferase; Humans; Immunosuppressive Agents; Lovastatin; Multiple Myeloma; Oxides; Protease Inhibitors; Pyrazines; Thalidomide

2005

Trials

4 trial(s) available for pyrazines and lovastatin

ArticleYear
The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia.
    Diabetic medicine : a journal of the British Diabetic Association, 1995, Volume: 12, Issue:3

    Topics: Apolipoproteins B; Bezafibrate; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Middle Aged; Phospholipids; Placebos; Pyrazines; Simvastatin; Triglycerides

1995
The impact of a short course of three lipid lowering drugs on fat oxidation during exercise in healthy volunteers.
    Postgraduate medical journal, 1993, Volume: 69, Issue:809

    Topics: Adult; Anticholesteremic Agents; Blood Pressure; Energy Metabolism; Exercise; Exercise Test; Exercise Tolerance; Fatty Acids, Nonesterified; Gemfibrozil; Heart Rate; Humans; Hydroxymethylglutaryl CoA Reductases; Hypolipidemic Agents; Lovastatin; Male; Oxidation-Reduction; Oxygen Consumption; Pyrazines; Random Allocation; Simvastatin; Single-Blind Method

1993
The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemia.
    Journal of internal medicine, 1997, Volume: 241, Issue:2

    Topics: Adult; Aged; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pyrazines; Simvastatin; Treatment Outcome; Triglycerides

1997
Short-term efficacy and tolerability of combination therapy with lovastatin and acipimox in Chinese patients with type 2 diabetes mellitus and mixed dyslipidemia.
    Journal of clinical pharmacology, 1998, Volume: 38, Issue:10

    Topics: Adult; Aged; Anticholesteremic Agents; China; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pyrazines

1998

Other Studies

5 other study(ies) available for pyrazines and lovastatin

ArticleYear
Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Journal of medicinal chemistry, 1992, May-29, Volume: 35, Issue:11

    Topics: Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry, Physical; Cholesterol; Dogs; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Molecular Structure; Pravastatin; Pyrazines; Pyrazoles; Pyridines

1992
Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome.
    Annals of clinical biochemistry, 1994, Volume: 31 ( Pt 4)

    Topics: Administration, Oral; Bezafibrate; Bilirubin; Colestipol; Gilbert Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Liver; Liver Function Tests; Lovastatin; Male; Middle Aged; Pravastatin; Pyrazines; Simvastatin

1994
Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Iodides; Lovastatin; Neoplasm Metastasis; Oxides; Pyrazines; Sirolimus; Thymus Gland; Thyroid Neoplasms; Tretinoin

2009
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
    Pharmacotherapy, 2009, Volume: 29, Issue:3

    Topics: Aged; Anticholesteremic Agents; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Lovastatin; Pyrazines; Rhabdomyolysis; Sitagliptin Phosphate; Triazoles

2009
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
    Diabetic medicine : a journal of the British Diabetic Association, 2020, Volume: 37, Issue:11

    Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides

2020